UCD, or urea cycle disorder, is a group of rare genetic conditions in which the body cannot properly remove ammonia from the blood. Ammonia is a toxic waste product created when the body breaks down protein. Normally, the liver converts ammonia into urea, which gets flushed out through urine. In people with a urea cycle disorder, one of the key enzymes or transport molecules in this conversion process is missing or not working correctly, so ammonia builds up to dangerous levels. The estimated incidence is about 1 in every 35,000 births.
How the Urea Cycle Works
The urea cycle is a chain of chemical reactions that takes place in the liver. It involves six enzymes and two transport molecules working in sequence to convert ammonia into urea. The first two steps happen inside the energy-producing compartments of liver cells (the mitochondria), where ammonia is combined with other molecules to form an intermediate compound. That compound is then shuttled into the main body of the cell, where the remaining steps transform it into urea. At the very end of the cycle, urea is released into the bloodstream, travels to the kidneys, and leaves the body in urine.
When any one of these enzymes or transporters is defective, the cycle stalls. There is no effective backup system for clearing ammonia, so it accumulates rapidly. This is why even a partial disruption of the cycle can cause serious problems.
Types of Urea Cycle Disorders
There are eight recognized forms of UCD, each tied to a specific enzyme or transporter deficiency:
- CPS1 deficiency: affects the first enzyme in the cycle
- OTC deficiency: the most common type, affecting the second enzyme
- ASS deficiency (citrullinemia): affects the third enzyme
- ASL deficiency (argininosuccinic aciduria): affects the fourth enzyme
- Arginase deficiency (hyperargininemia): affects the final enzyme, typically causing a milder, more neurological presentation rather than severe ammonia spikes in newborns
- NAGS deficiency: affects an enzyme that produces a cofactor the cycle needs to start
- ORNT1 deficiency (HHH syndrome): affects a transporter that moves amino acids into the mitochondria
- Citrin deficiency: affects a transporter involved in moving molecules between cell compartments
All forms are inherited. Most follow an autosomal recessive pattern, meaning a child must receive a defective gene copy from both parents. OTC deficiency is the exception: it is X-linked, so it primarily affects males, though females who carry one copy of the gene can still develop symptoms ranging from mild to severe.
Symptoms in Newborns
Severe deficiency of any of the first four enzymes or the cofactor-producing enzyme typically causes a crisis within the first few days of life, as the newborn begins taking in breast milk or formula and processing protein for the first time. Early signs are nonspecific: the baby becomes lethargic, irritable, and starts vomiting. As ammonia levels climb, breathing may become rapid or labored because ammonia stimulates the brain’s respiratory center. Without treatment, the situation can progress to seizures, coma, and death.
High ammonia is especially dangerous to the brain. It causes brain cells called astrocytes to swell with excess fluid, leading to increased pressure inside the skull. This swelling can cause permanent brain injury even if the crisis is eventually controlled.
Late-Onset Symptoms
Not everyone with a urea cycle disorder becomes sick as a newborn. People with partial enzyme deficiency may not develop symptoms until childhood, adolescence, or even adulthood. A crisis is often triggered by something that increases the body’s protein load or breakdown: an illness, surgery, fasting, or a high-protein meal.
Milder episodes look like headaches, nausea, confusion, and poor coordination. More severe episodes bring on slurred speech, disorientation, hand tremors, and difficulty walking. If ammonia levels rise above a critical threshold, seizures, loss of consciousness, and life-threatening brain swelling can follow. Some people with chronic, low-grade ammonia elevation develop intellectual disability, learning difficulties, or behavioral and psychiatric symptoms over time without ever having an obvious acute crisis.
How UCD Is Diagnosed
The hallmark finding is elevated ammonia in the blood. When a doctor suspects a urea cycle disorder, a blood sample must be drawn carefully and processed within 15 minutes to get an accurate reading, since ammonia levels in a sample can change quickly at room temperature.
Once high ammonia is confirmed, doctors measure the levels of specific amino acids in the blood. The pattern of which amino acids are elevated or low points to which enzyme in the cycle is not working. For example, very high citrulline suggests ASS deficiency, while low citrulline with elevated orotic acid in urine points toward OTC deficiency. Genetic testing can then confirm the exact mutation. Some forms of UCD are now included in newborn screening programs, which can catch the condition before symptoms appear.
Managing UCD Day to Day
Daily management revolves around two goals: limiting how much ammonia the body produces and helping the body get rid of what it does produce.
Low-Protein Diet
Because ammonia comes from protein breakdown, people with UCD follow a carefully controlled low-protein diet. The amount of protein allowed varies widely from person to person and must be individualized. Too little protein causes its own problems, since the body needs protein to grow and function normally. Many patients cannot get enough essential amino acids from food alone, so they take amino acid supplements to fill the gap. Tube feeding is sometimes used when oral intake is not sufficient, especially in young children. People on long-term protein restriction are also at risk for deficiencies in vitamin B12, iron, calcium, zinc, and copper, so regular nutritional monitoring matters.
Nitrogen-Scavenging Medications
These are drugs that give ammonia an alternative exit route from the body. The most commonly used is sodium phenylbutyrate, which is converted in the body into a compound that latches onto a nitrogen-carrying amino acid (glutamine), forming a molecule the kidneys can excrete in urine. Sodium benzoate works similarly, binding nitrogen through a different amino acid (glycine). Both drugs have drawbacks: sodium phenylbutyrate can suppress appetite, alter taste, cause body odor, and disrupt menstrual cycles in about a quarter of women who take it after puberty.
Some patients also take supplemental arginine or citrulline, amino acids that feed into the urea cycle and help it run more efficiently despite the enzyme gap.
What Happens During a Crisis
An acute hyperammonemic crisis is a medical emergency. The immediate priority is stopping all protein intake to cut off the ammonia supply, while providing calories through intravenous sugar and fat solutions to prevent the body from breaking down its own muscle for energy (which would release more ammonia). Nitrogen-scavenging drugs are given intravenously at high doses. Ammonia levels are checked every three hours to track whether treatment is working.
If ammonia does not drop quickly enough with medications alone, dialysis may be needed to physically filter it from the blood. Speed matters: the longer ammonia stays elevated, the greater the risk of irreversible brain damage.
Liver Transplant as a Definitive Treatment
Because the urea cycle operates in the liver, a liver transplant can essentially cure the metabolic defect. After transplantation, patients no longer need a restricted diet, and studies show zero episodes of hyperammonemia or metabolic crises in transplanted patients during follow-up. In one study of 16 transplanted UCD patients, overall survival was 100% and graft survival was 94%.
Transplant does not, however, reverse brain damage that has already occurred. Patients who had normal development before the transplant maintained their cognitive abilities afterward. Those who had developmental delays before surgery remained stable but did not improve. This is a key reason doctors often recommend transplantation early, particularly for patients with severe neonatal-onset disease, to prevent neurological damage from accumulating over years of repeated crises and chronic ammonia exposure. The decision is typically driven by how often a patient requires hospitalization despite standard treatment, their neurological trajectory, and whether the liver itself is failing.
Long-Term Outlook
The prognosis for UCD depends heavily on the severity of the enzyme deficiency and how quickly it is recognized. People with partial deficiencies who are diagnosed before major crises occur can often lead relatively normal lives with dietary management and medication. Those who survive severe neonatal crises frequently have some degree of intellectual disability or developmental delay, with the severity closely tied to how high ammonia rose and how long it stayed elevated before treatment.
Many adult UCD patients experience ongoing learning difficulties, communication challenges, or the need for some level of support. Regular monitoring of ammonia levels, careful dietary planning, and having an emergency protocol in place for illness or other triggers remain part of life for anyone managing this condition without a transplant.